- Published at
- by manilatimes.net
positive
positive
News for Arch Biopartners Inc. (ARCH.V)
- Published at
- by financialpost.com
neutralneutralArch Biopartners Arranges Non-Brokered Private Placement
TORONTO, March 05, 2025 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a …- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
positivepositive- Published at
- by financialpost.com
mixedmixedArch Biopartners Arranges Non-Brokered Private Placement
TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a n…- Published at
- by financialpost.com
positivepositiveArch Biopartners Arranges Non-Brokered Private Placement
TORONTO, July 29, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a n…- Published at
- by markets.businessinsider.com
positivepositiveArch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced toda...- Published at
- by financialpost.com
negativenegativeArch Biopartners Clinical Team Publishes Data from Phase II Trial for LSALT Peptide Targeting Organ Inflammation in Hospitalized Patients Infected with SARS-CoV-2
British Medical Journal Open publishes paper detailing the results of the international Phase II human trial for LSALT peptide targeting acute lung and kidney…- Published at
- by financialpost.com
neutralneutralUniversity of Calgary Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
TORONTO, March 15, 2024 (GLOBE NEWSWIRE) —- Published at
- by financialpost.com
positivepositive- Published at
- by financialpost.com
positivepositive- Published at
- by financialpost.com
positivepositiveGrant of Options to Directors and Officers
TORONTO, Dec. 18, 2023 (GLOBE NEWSWIRE) —- Published at
- by prnewswire.com
mixedmixedPeptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
/PRNewswire/ -- The